CD157 selectively identifies hPSCs with enhanced hepatic differentiation capacity

References

[1] Zhang J , Zhao J , Dahan P , et al. Metabolism in pluripotent stem cells and early mammalian development. Cell Metab 2018; 27: 332- 8.

[2] Liu K , Cao J , Shi X , et al. Cellular metabolism and homeostasis in pluripotency regulation. Protein Cell 2020; 11: 630- 40.

[3] Cahan P , Daley GQ . Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol 2013; 14: 357- 68.

[4] Yang S , Cho Y , Jang J . Single cell heterogeneity in human pluripotent stem cells. BMB Rep 2021; 54: 505- 15.

[5] Xie N , Zhang L , Gao W , et al. NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther 2020; 5: 1- 37.

[6] Glowacki G , Braren R , Firner K , et al. The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. Protein Sci 2002; 11: 1657- 70.

[7] Ortolan E , Vacca P , Capobianco A , et al. CD157, the Janus of CD38 but with a unique personality. Cell Biochem Funct 2002; 20: 309- 22.

[8] Wakabayashi T , Naito H , Suehiro J-I , et al. CD157 marks tissueresident endothelial stem cells with homeostatic and regenerative properties. Cell Stem Cell 2018; 22: 384- 97.e6.

[9] Uhlen M , Fagerberg L , Hallström BM , et al. Proteomics. Tissue-based map of the human proteome. Science 2015; 347: 1260419.

RIGHTS & PERMISSIONS

2024 The Author(s). Published by Oxford University Press on behalf of Higher Education Press.